REQUEST A DEMO
Total
USD $0.00
Search more companies

FKP Stavropoliskaya Biofabrika (ФКП Ставропольская Биофабрика) (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: FKP Stavropoliskaya Biofabrika Profile Updated: October 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

FKP Stavropoliskaya Biofabrika (ФКП Ставропольская Биофабрика) is an enterprise based in Russia. Its main office is in Stavropol. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. It was established on October 31, 2002. The company’s latest financial report indicates a net sales revenue increase of 42.99% in 2024. Its’ total assets recorded a growth of 66.24%. The net profit margin of FKP Stavropoliskaya Biofabrika (ФКП Ставропольская Биофабрика) increased by 14.24% in 2024.

Headquarters
Biologicheskaya, 18
Stavropol; Stavropol Krai; Postal Code: 355019

Contact Details: Purchase the FKP Stavropoliskaya Biofabrika (ФКП Ставропольская Биофабрика) report to view the information.

Basic Information
Registered Capital:
Purchase the FKP Stavropoliskaya Biofabrika (ФКП Ставропольская Биофабрика) report to view the information.
Financial Auditors:
Purchase the FKP Stavropoliskaya Biofabrika (ФКП Ставропольская Биофабрика) report to view the information.
Incorporation Date:
October 31, 2002
Key Executives
Purchase this report to view the information.
Acting Director
Subsidiaries
Rao Rosagrobioprom
0.21%
Company Performance
Financial values in the chart are available after FKP Stavropoliskaya Biofabrika (ФКП Ставропольская Биофабрика) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
42.99%
Total operating revenue
42.99%
Operating profit (EBIT)
96.35%
Net Profit (Loss) for the Period
103.37%
Total assets
66.24%
Total equity
66.32%
Operating Profit Margin (ROS)
13.02%
Net Profit Margin
14.24%
Return on Equity (ROE)
4.42%
Quick Ratio
-0.68%
Cash Ratio
-0.39%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?